In 47 pairs of oxaliplatin‐resistant HCC samples, RT‐PCR showed that NR2F1‐AS1 was also significantly up‐regulated compared with matched oxaliplatin‐sensitive samples (Figure 1B). Here, NR2F1 is linked to hepatocellular carcinoma.